Our Leadership

Board Members

Masashi Miyamoto, Ph.D. (Profile)
Representative Director, Chairman & CEO

Masashi Miyamoto, Ph.D. Profile

Apr. 1985 Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited)
Apr. 2011 Director, Regulatory Affairs Department, Pharmacovigilance and Quality Assurance Division, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Mar. 2012 Executive Officer, Director, Regulatory Affairs Department, Pharmacovigilance and Quality Assurance Division, Kyowa Hakko Kirin Co., Ltd.
Jul. 2014 Executive Officer, Director, Strategic Product Portfolio Department and Regulatory Affairs Department, Pharmacovigilance and Quality Assurance Division, Kyowa Hakko Kirin Co., Ltd.
Apr. 2015 Executive Officer, Director, Strategic Product Portfolio Department, Kyowa Hakko Kirin Co., Ltd.
Mar. 2017 Director of the Board, Managing Executive Officer, Strategic Product Portfolio Department, Kyowa Hakko Kirin Co., Ltd.
Apr. 2017 Director of the Board, Managing Executive Officer, Director, Corporate Strategy & Planning Department, Kyowa Hakko Kirin Co., Ltd.
Mar. 2018 Representative Director of the Board, President, Kyowa Hakko Kirin Co., Ltd.
Apr. 2024 Representative Director of the Board, President & Chief Executive Officer(CEO), Kyowa Kirin Co., Ltd.
Mar. 2025 Representative Director of the Board, Chairman & Chief Executive Officer(CEO), Kyowa Kirin Co., Ltd. (to present)
Abdul Mullick, Ph.D. (Profile)
Representative Director, President & COO

Abdul Mullick, Ph.D. Profile

Jan. 1999 Global Marketing Director, Diabetes, Hoechst Marion Roussel Ltd. (presently Sanofi-Aventis Pharma AG)
Jan. 2005 Senior Global Brand Director, Diabetes, Novartis Pharma AG
Dec. 2007 EMEA Business Unit Head, Genzyme Corp.
Jan. 2009 Vice President Commercial Operations – Japan, Asia-Pac, Australia & China, Genzyme Corp.
Jan. 2011 Vice President, Head of Global Marketing, Rare Diseases, Genzyme Corp.
Jul. 2013 Vice President & General Manager, Endocrinology and Cardiology, Rare Diseases, Genzyme USA
Sep. 2014 Executive Vice President, Head of Global Marketing, Vifor Pharma Ltd
Mar. 2018 Executive Vice President, Rare Disease Head, Kyowa Kirin International plc
Apr. 2019 President, Kyowa Kirin International plc
Jan. 2023 Managing Executive Officer, Vice Chief International Business Officer, Kyowa Kirin Co., Ltd.
Mar. 2023 Managing Executive Officer, Chief International Business Officer, Kyowa Kirin Co., Ltd.
Apr. 2024 Managing Executive Officer, Chief International Business Officer (CIBO), Kyowa Kirin Co., Ltd.
Mar. 2025 Representative Director of the Board, President and Chief Operating Officer (COO) (to present)
Takeyoshi Yamashita, Ph.D. (Profile)
Director
Executive Vice President & CMO

Takeyoshi Yamashita, Ph.D. Profile

Apr. 1987 Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited)
Apr. 2010 Director, Innovative Drug Discovery Laboratories, Research Division, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Apr. 2012 Director, Research Planning Department, Research Division, Kyowa Hakko Kirin Co., Ltd.
Apr. 2015 Director, Regulatory Affairs Department, Pharmacovigilance and Quality Assurance Division, Kyowa Hakko Kirin Co., Ltd.
Mar. 2017 Executive Officer
Director, Regulatory Affairs Department, Kyowa Hakko Kirin Co., Ltd.
Mar. 2019 Executive Officer
Director, Corporate Strategy and Planning Department, Kyowa Hakko Kirin Co, Ltd.
Mar. 2021 Managing Executive Officer
Director, Corporate Strategy and Planning Department, Kyowa Kirin Co., Ltd.
Mar. 2022 Managing Executive Officer
Vice President, Head of Strategy Division, Kyowa Kirin Co., Ltd.
Mar. 2023 Director of the Board, Senior Managing Executive officer, Head of Strategy Division, Kyowa Kirin Co., Ltd.
Apr. 2023 Director of the Board, Senior Managing Executive officer, Kyowa Kirin Co., Ltd.
Apr. 2024 Director of the Board, Senior Managing Executive officer & Chief Medical Officer(CMO), Kyowa Kirin Co., Ltd.
Mar. 2025 Director of the Board, Executive Vice President & Chief Medical Officer(CMO), Kyowa Kirin Co., Ltd. (to present)
Daisuke Fujiwara, Ph.D. (Profile)
Director

Daisuke Fujiwara, Ph.D. Profile

Apr. 1995 Joined Kirin Brewery Company, Limited（presently Kirin Holdings Company, Limited）
Feb. 2005 Visiting Researcher, RIKEN Research Center for Allergy and Immunology
Sep. 2005 Postdoctoral Fellow, David Geffen School of Medicine at UCLA（USA）
Nov. 2007 Senior Researcher, Central Laboratories for Key Technologies, Kirin Holdings Company, Limited
May. 2014 Part-time Lecturer, Graduate School of Agricultural and Life Sciences, The University of Tokyo（to present）
Mar. 2021 General Manager, Health Science Department, Kirin Holdings Company, Limited
Mar. 2023 Executive Officer and General Manager of Institute of Health Sciences, Kirin Holdings Company, Limited
Mar. 2025 Director of the Board, Kyowa Kirin Co., Ltd.（to present）
Senior Executive Officer, President of R&D Division, Kirin Holdings Company, Limited（to present）
Takashi Oyamada, MBA (Profile)
Director

Takashi Oyamada, MBA Profile

Apr. 1979 Joined The Mitsubishi Bank, Limited (presently MUFG Bank, Ltd.)
Jan. 2006 Executive Officer, The Bank of Tokyo-Mitsubishi UFJ, Ltd. (presently MUFG Bank, Ltd.)
Jan. 2009 Managing Executive Officer, The Bank of Tokyo-Mitsubishi UFJ, Ltd.
Jun. 2009 Managing Director, The Bank of Tokyo Mitsubishi UFJ, Ltd.
Member of the Board of Directors, Mitsubishi UFJ Financial Group, Inc.
May. 2012 Managing Executive Officer, The Bank of Tokyo-Mitsubishi UFJ, Ltd.
May 2013 Senior Managing Executive Officer, The Bank of Tokyo-Mitsubishi UFJ, Ltd.
Jun. 2014 Representative Director, Deputy President, The Bank of Tokyo-Mitsubishi UFJ, Ltd.
Jun. 2015 Member of the Board of Directors, Representative Corporate Executive, Deputy President and COO, Mitsubishi UFJ Financial Group, Inc.
Apr. 2016 Member of the Board of Directors, President & CEO, The Bank of Tokyo-Mitsubishi UFJ, Ltd.
Member of the Board of Directors, Mitsubishi UFJ Financial Group, Inc.
Jun. 2017 Senior Advisor, The Bank of Tokyo-Mitsubishi UFJ, Ltd. (to present)
Jun. 2018 Director and Vice Chair, The Japan Institute of International Affairs (to present)
Dec. 2018 Outside Director, Mitsubishi Research Institute DCS Co., Ltd. (to present)
Jun. 2019 Outside Director, Mitsubishi Electric Corporation
Outside Director, Isetan Mitsukoshi Holdings Ltd.
Mar. 2021 Outside Director of the Board, Kyowa Kirin Co., Ltd. (to present)
Yoshihisa Suzuki, MBA (Profile)
Director

Yoshihisa Suzuki, MBA Profile

Apr. 1979 Joined ITOCHU Corporation
Jun. 2003 Executive Officer, ITOCHU Corporation
Apr. 2006 Managing Executive Officer, ITOCHU Corporation
Executive Vice President and CAO, ITOCHU International Inc.
Apr. 2007 President and CEO, ITOCHU International Inc.
Jun. 2011 Executive Vice President, JAMCO Corporation
Jun. 2012 President and CEO, JAMCO Corporation
Jun. 2016 Senior Managing Executive Officer, Member of the Board, ITOCHU Corporation
Apr. 2018 President and Chief Operating Officer (COO), Member of the Board, ITOCHU Corporation
Apr. 2020 President and Chief Operating Officer (COO), Chief Digital Officer (CDO), and Chief Information Officer (CIO), Member of the Board, ITOCHU Corporation
Apr. 2021 Vice Chairman, Member of the Board, ITOCHU Corporation
Mar. 2022 Outside Director of the Board, Kyowa Kirin Co., Ltd. (to present)
Apr. 2022 Vice Chairman, ITOCHU Corporation
Jun. 2022 Outside Director, OMRON Corporation (to present)
Apr. 2023 Senior Vice Representative for External Affairs, ITOCHU Corporation
Apr. 2024 Advisory Member, ITOCHU Corporation (to present)
Nov. 2024 Representative Director, Rolling Hills, Co., Ltd. (to present)
Rumiko Nakata (Profile)
Director

Rumiko Nakata Profile

Apr. 1979 Joined Esso Sekiyu K.K.
Apr. 1996 Joined Center for Socio-Economic Research K.K.
Apr. 2000 Joined Pfizer K.K. (Pfizer Japan)
Dec. 2011 Head of HR and Global Operations, Pfizer K.K.
Mar. 2012 Corporate Officer, Pfizer K.K.
Jan. 2014 Director of the Board, Corporate Officer, Pfizer K.K.
Mar. 2018 Executive Officer, Diversity & Inclusion, Mitsubishi Chemical Corporation.
Apr. 2019 Managing Executive Officer, Supervising-Human Resources Department, Mitsubishi Chemical Corporation.
Apr. 2020 Director of the Board, Managing Executive Officer, Supervising – Administration Dept., Public Relations Dept., Human Resources Dept., Mitsubishi Chemical Corporation.
Mar. 2023 Outside Director of the Board, Kyowa Kirin Co., Ltd. (to present)
Jun. 2024 Outside Director, Denka Company Limited(to present)
Hiroshi Kanno, MBA (Profile)
Director

Hiroshi Kanno, MBA Profile

Apr. 1983 Joined Nikken Sekkei Ltd.
Aug. 1991 Joined Boston Consulting Group, Inc.（presently Boston Consulting Group, LLC）
Jan. 2000 Partner & Managing Director, Boston Consulting Group, Inc. （presently Boston Consulting Group, LLC）
Jul. 2008 Professor, Hitotsubashi University Graduate School of International Corporate Strategy
Jun. 2011 Outside Director, OMRON Healthcare Co., Ltd.
Apr. 2012 Dean, Hitotsubashi University Graduate School of International Corporate Strategy
Jun. 2015 Outside Auditor, STANLEY ELECTRIC Co., Ltd.
Sep. 2016 Professor, Waseda Business School（Graduate School of Business and Finance）（to present）
Dec. 2016 Director, Unicharm Kyoshin Foundation（to present）
Sep. 2017 Outside Director, ERI Holdings Co., Ltd.
Sep. 2018 Director, Waseda University Institute for Business and Finance（to present）
Apr. 2020 Visiting Professor, The Open University of Japan（to present）
Jul. 2022 Director, Laboro.AI Inc.（to present）
Feb. 2023 Visiting Professor, School of Business, Aalto University（Finland）
Mar. 2025 Outside Director of the Board, Kyowa Kirin Co., Ltd.（to present）
Yukiko Ito, Ph.D. (Profile)
Director

Yukiko Ito, Ph.D. Profile

Apr. 2006 Assistant Professor, Faculty of Economics, Tokyo Keizai University
Apr. 2009 Associate Professor, Department of Economics, Faculty of Humanities and Social Sciences, Tokyo Gakugei University
Jul. 2015 Committee member, Committee for the Promotion of Integrated Economic and Fiscal Reforms, Cabinet Office
Apr. 2018 Professor, College of Policy Studies, Tsuda University
Jul. 2018 Subcommittee Member, Pharmaceuticals and Medical Devices System, Health Sciences Council, Ministry of Health, Labor and Welfare（to present）
Apr. 2024 Director, Japan Community Healthcare Organization（to present）
Jun. 2024 Director, Pfizer Health Research Foundation（to present）
Mar. 2025 Outside Director of the Board, Kyowa Kirin Co., Ltd.（to present）
Apr. 2025 Professor, Graduate School of Business and Commerce, Keio University（to present）

Audit & Supervisory Board Members

Hiroshi Komatsu (Profile)

Hiroshi Komatsu Profile

Apr. 1986 Joined Kyowa Hakko Kogyo Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Feb. 2009 CFO, Hematech, Inc.
Apr. 2012 Manager, Corporate Planning Department, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Apr. 2015 Deputy Director, General Affairs Department, Kyowa Hakko Kirin Co., Ltd.
Apr. 2016 Deputy Director, General Affairs Department, and Leader, Corporate Secretariat Group, General Affairs Department, Kyowa Hakko Kirin Co., Ltd.
Mar. 2018 Audit & Supervisory Board Member (Full-time), Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.) (to present)

Hajime Kobayashi (Profile)

Hajime Kobayashi Profile

Apr. 1989 Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited)
Apr. 2011 Director, General Manager of Corporate Planning, Interfood Shareholdings Company (Vietnam)
Jan. 2013 Deputy Director, Corporate Strategy, Kirin Holdings Company, Limited
Apr. 2018 Head of Global Personnel Section, Personnel & General Affairs, Kirin Holdings Company, Limited
Mar. 2020 General Manager, Internal Audit Dept, Kirin Holdings Company, Limited
Mar. 2022 Executive Officer, General Manager, Internal Audit Dept, Kirin Holdings Company, Limited
Mar. 2024 Outside Audit & Supervisory Board Member (Full-time), Kyowa Kirin Co., Ltd. (to present)

Mayumi Tamura (Profile)

Mayumi Tamura Profile

Apr. 1983 Joined Sony Corporation (presently Sony Group Corporation)
Sep. 1991 Joined JOHNSON COMPANY, LIMITED
Jul. 2002 Executive Officer, Johnson Diversey Co. Ltd. (presently CxS Corporation)
Dec. 2004 CFO, adidas Japan K.K.
Jun. 2007 Executive Officer, Senior Vice President and CFO, Seiyu KK
May. 2010 Executive Officer, SVP and CFO, Walmart Japan Holdings GK (presently Seiyu Holdings Company, Limited)
Executive Officer, SVP and CFO, Seiyu GK
(presently Seiyu KK)
Jun. 2015 Outside Corporate Auditor, Honda Motor Co., Ltd.
Jun. 2017 Outside Director, Honda Motor Co., Ltd.
Outside Director, Hitachi High-Technologies Corporation (presently Hitachi High-Tech Corporation)
Jun. 2019 Outside Director, SHIMIZU CORPORATION (to present)
Mar. 2022 Outside Audit & Supervisory Board Member, Kyowa Kirin Co., Ltd. (to present)
Jun. 2022 Outside Director, LIXIL Corporation(to present)

Toru Ishikura (Profile)

Toru Ishikura Profile

Apr. 1989 Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited)
Mar. 2015 General Manager, Technology Management Department, Research & Development Division, Kirin Company, Limited (presently Kirin Holdings Company, Limited)
Apr. 2015 General Manager, Research & Development Strategy Department, Research & Development Division, Kirin Company, Limited
Mar. 2018 Executive Officer, General Manager, Research & Development Strategy Department, Research & Development Division, Kirin Company, Limited
Apr. 2019 Executive Officer, Vice President of Research & Development Division and General Manager, Research & Development Strategy Department, Research & Development Division, Kirin Holdings Company, Limited
Mar.- Apr. 2020 Director of the Board, KYOWA HAKKO BIO CO. LTD.
Executive Officer, General Manager, Health Business Strategy Office, Corporate Strategy Department, Kirin Holdings Company, Limited
Apr. 2022 Executive Officer, General Manager, Health Science Business Department, Health Science Business Division, Kirin Holdings Company, Limited
Mar. 2023 Audit & Supervisory Board Member, Kyowa Kirin Co., Ltd. (to present)
Company Auditor (Full-time), Kirin Holdings Company, Limited (to present)

Yoko Wachi (Profile)

Yoko Wachi Profile

Apr. 1989 Joined Kajitani Law Offices
Admitted in Japan（Dai-Ichi Tokyo Bar Association）
Apr. 2006 Mediator of Family Conciliations, Tokyo Family Court（to present）
Jun. 2015 Outside Audit & Supervisory Board Member of NICHIAS CORPORATION
Mar. 2016 Outside Audit & Supervisory Board Member of Otsuka Holdings Co., Ltd.
Jan. 2019 Partner, Kajitani Law Offices（to present）
Apr. 2019 Vice President of the Tokyo Association of Family Conciliations
Jun. 2019 Outside Director of NICHIAS CORPORATION（to present）
Jun. 2023 Outside Director of S.T. CORPORATION（to present）
Mar. 2025 Outside Audit & Supervisory Board Member, Kyowa Kirin Co., Ltd.（to present）

One Kyowa Kirin Leadership

Masashi Miyamoto, Ph.D. (Profile)
Chief Executive Officer (CEO) and Region President, JAPAC

Masashi Miyamoto, Ph.D. Profile

Apr. 1985 Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited)
Apr. 2011 Director, Regulatory Affairs Department, Pharmacovigilance and Quality Assurance Division, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Mar. 2012 Executive Officer, Director, Regulatory Affairs Department, Pharmacovigilance and Quality Assurance Division, Kyowa Hakko Kirin Co., Ltd.
Jul. 2014 Executive Officer, Director, Strategic Product Portfolio Department and Regulatory Affairs Department, Pharmacovigilance and Quality Assurance Division, Kyowa Hakko Kirin Co., Ltd.
Apr. 2015 Executive Officer, Director, Strategic Product Portfolio Department, Kyowa Hakko Kirin Co., Ltd.
Mar. 2017 Director of the Board, Managing Executive Officer, Strategic Product Portfolio Department, Kyowa Hakko Kirin Co., Ltd.
Apr. 2017 Director of the Board, Managing Executive Officer, Director, Corporate Strategy & Planning Department, Kyowa Hakko Kirin Co., Ltd.
Mar. 2018 Representative Director of the Board, President, Kyowa Hakko Kirin Co., Ltd.
Apr. 2024 Representative Director of the Board, President & Chief Executive Officer(CEO), Kyowa Kirin Co., Ltd.
Mar. 2025 Representative Director of the Board, Chairman & Chief Executive Officer(CEO), Kyowa Kirin Co., Ltd. (to present)
Abdul Mullick, Ph.D. (Profile)
Chief Operating Officer (COO)

Abdul Mullick, Ph.D. Profile

Jan. 1999 Global Marketing Director, Diabetes, Hoechst Marion Roussel Ltd. (presently Sanofi-Aventis Pharma AG)
Jan. 2005 Senior Global Brand Director, Diabetes, Novartis Pharma AG
Dec. 2007 EMEA Business Unit Head, Genzyme Corp.
Jan. 2009 Vice President Commercial Operations – Japan, Asia-Pac, Australia & China, Genzyme Corp.
Jan. 2011 Vice President, Head of Global Marketing, Rare Diseases, Genzyme Corp.
Jul. 2013 Vice President & General Manager, Endocrinology and Cardiology, Rare Diseases, Genzyme USA
Sep. 2014 Executive Vice President, Head of Global Marketing, Vifor Pharma Ltd
Mar. 2018 Executive Vice President, Rare Disease Head, Kyowa Kirin International plc
Apr. 2019 President, Kyowa Kirin International plc
Jan. 2023 Managing Executive Officer, Vice Chief International Business Officer, Kyowa Kirin Co., Ltd.
Mar. 2023 Managing Executive Officer, Chief International Business Officer, Kyowa Kirin Co., Ltd.
Apr. 2024 Managing Executive Officer, Chief International Business Officer (CIBO), Kyowa Kirin Co., Ltd.
Mar. 2025 Representative Director of the Board, President and Chief Operating Officer (COO) (to present)
Takeyoshi Yamashita, Ph.D. (Profile)
Chief Medical Officer (CMO)

Takeyoshi Yamashita, Ph.D. Profile

Apr. 1987 Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited)
Apr. 2010 Director, Innovative Drug Discovery Laboratories, Research Division, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Apr. 2012 Director, Research Planning Department, Research Division, Kyowa Hakko Kirin Co., Ltd.
Apr. 2015 Director, Regulatory Affairs Department, Pharmacovigilance and Quality Assurance Division, Kyowa Hakko Kirin Co., Ltd.
Mar. 2017 Executive Officer
Director, Regulatory Affairs Department, Kyowa Hakko Kirin Co., Ltd.
Mar. 2019 Executive Officer
Director, Corporate Strategy and Planning Department, Kyowa Hakko Kirin Co, Ltd.
Mar. 2021 Managing Executive Officer
Director, Corporate Strategy and Planning Department, Kyowa Kirin Co., Ltd.
Mar. 2022 Managing Executive Officer
Vice President, Head of Strategy Division, Kyowa Kirin Co., Ltd.
Mar. 2023 Director of the Board, Senior Managing Executive officer, Head of Strategy Division, Kyowa Kirin Co., Ltd.
Apr. 2023 Director of the Board, Senior Managing Executive officer, Kyowa Kirin Co., Ltd.
Apr. 2024 Director of the Board, Senior Managing Executive officer & Chief Medical Officer(CMO), Kyowa Kirin Co., Ltd.
Mar. 2025 Director of the Board, Executive Vice President & Chief Medical Officer(CMO), Kyowa Kirin Co., Ltd. (to present)
Tomohiro Sudo, M.S, MBA (Profile)
Chief International Business Officer (CIBO)

Tomohiro Sudo, M.S, MBA Profile

Apr. 1993 Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Ltd.)
Feb. 2001 Manager, Clinical Development, GEMINI SCIENCE, INC. (California, USA)
Apr. 2004 Vice President, GEMINI SCIENCE, INC. (California, USA)
Sep. 2009 Manager, Group No.2, Strategic Product Department, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Apr. 2014 Deputy Director, Strategic Product Portfolio Department, Kyowa Hakko Kirin Co., Ltd
Apr. 2016 Global Product Lead for Crysvita, Kyowa Kirin International Plc (UK)
Jan. 2017 Executive Vice President of Kyowa Kirin International Plc (UK)
Apr. 2020 Executive Officer
Director, Strategic Product Planning Department, Kyowa Kirin Co., Ltd.
Apr. 2021 Executive Officer
Director, Global Product Strategy Department, Kyowa Kirin Co., Ltd. (to present)
Apr. 2022 Executive Officer
Director, Global Product Strategy Department, Strategy Division, Kyowa Kirin Co., Ltd.
Apr. 2024 Executive Officer
Director, Global Product Strategy Department, Kyowa Kirin Co., Ltd.
Mar. 2025 Managing Executive Officer and Chief International Business Officer (CIBO), Kyowa Kirin Co., Ltd.(to present)
Yasuo Fujii, MBA (Profile)
Chief Strategy Officer (CSO)

Yasuo Fujii, MBA Profile

Apr. 1988 Joined Kyowa Hakko Kogyo Co.,Ltd. (presently Kyowa Kirin Co., Ltd.)
Sep. 2011 Senior Vice President, ProStrakan, plc (presently Kyowa Kirin International, plc)
Sep. 2012 Executive Vice President, ProStrakan, plc
Jan. 2017 Deputy Director, Overseas Business Department, Kyowa Hakko Kirin (presently Kyowa Kirin Co.,Ltd.)
Mar. 2018 Executive Officer
Director, Business Development, Kyowa Hakko Kirin Co., Ltd.
Mar. 2023 Managing Executive Officer
Director, Business Development, Kyowa Kirin Co., Ltd.
Apr. 2023 Managing Executive Officer, Vice President, Head of Strategy Division, Kyowa Kirin Co., Ltd.
Apr. 2024 Managing Executive Officer and Chief Strategy Officer (CSO), Kyowa Kirin Co., Ltd. (to present)
Mitsuru Kameyama (Profile)
Chief Digital Transformation Officer (CDXO)

Mitsuru Kameyama Profile

Apr. 1980 Joined Nissan Motor Co., Ltd.,
Apr. 2005 Head of Information Systems Division, Dongfeng Motor Corporation (a joint venture in China)
Apr. 2012 General Manager of the Information Planning Department, Shiseido Company, Limited
Apr. 2013 President and CEO, Shiseido Information Network Co., Ltd.
Jan. 2016 Executive Officer and CITO (Chief Information Technology Officer), Shiseido Company, Limited
Feb. 2020 CDO (Chief Digital Officer), Mitsubishi Materials Corporation
Jan. 2023 Senior Executive Advisor, Globe-ing Inc.
Apr. 2025 Executive Officer
Chief Digital Transformation Officer (CDXO) and Head of ODX Department, Kyowa Kirin Co., Ltd. (to present)
Yoshiko Mori (Profile)
Chief Compliance Officer (CCO)

Yoshiko Mori Profile

Apr. 1992 Joined Kyowa Hakko Kogyo Co., Ltd.(presently Kyowa Kirin Co., Ltd.)
Apr. 2009 Manager of Pharmacovigilance, Kyowa Hakko Kirin Co., Ltd.(presently Kyowa Kirin Co., Ltd.)
Oct. 2009 Manager of Human resources, Kyowa Hakko Kirin Co., Ltd.
Apr. 2014 Senior manager, Pharmacovigilance Division, Kyowa Hakko Kirin Co., Ltd.
Sep. 2019 Director of Pharmacovigilance, Kyowa Hakko Kirin Co., Ltd.
Jan. 2020 Vice Division Head of Pharmacovigilance, Kyowa Kirin Co., Ltd.
Dec. 2021 Vice President, Head of Pharmacovigilance Division, Kyowa Kirin Co., Ltd.
Mar. 2022 Executive Officer
Vice President, Head of Pharmacovigilance Division, Kyowa Kirin Co., Ltd.
Mar. 2024 Executive Officer
Director, CSR Management Department, Kyowa Kirin Co., Ltd.
Marketing Supervisor-General, Kyowa Kirin Co., Ltd. (to present)
Mar. 2025 Managing Executive Officer and Chief Compliance Officer (CCO), Kyowa Kirin Co., Ltd. (to present)
Motohiko Kawaguchi (Profile)
Chief Financial Officer (CFO)

Motohiko Kawaguchi Profile

Apr. 1986 Joined Kyowa Hakko Kogyo Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Mar. 2012 Director, Accounting Department, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Mar. 2018 Executive Officer
Director, Accounting Department, Kyowa Hakko Kirin Co., Ltd.
Jul. 2019 Executive Officer
Director, Finance Department, Kyowa Kirin Co., Ltd.
Mar. 2022 Managing Executive Officer
Director, Finance Department, Kyowa Kirin Co., Ltd.
Apr. 2024 Managing Executive Officer and Chief Financial Officer (CFO) Kyowa Kirin Co., Ltd. (to present)
Shoko Itagaki (Profile)
Chief People Officer (CPO) & Global Human Resources Head

Shoko Itagaki Profile

Apr. 1995 Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited)
Mar. 2019 Director, Regulatory Affairs Department, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Mar. 2021 Executive Officer
Director, Corporate Strategy & Planning Department, Kyowa Kirin Co., Ltd.
Apr. 2022 Executive Officer
Director, Corporate Planning Department, Strategy Division, Kyowa Kirin Co., Ltd.
Apr. 2024 Executive Officer and Chief People Officer (CPO), Kyowa Kirin Co., Ltd.
Mar. 2025 Managing Executive Officer and Chief People Officer (CPO), Kyowa Kirin Co., Ltd. (to present)
Toshiyuki Kurata, MBA (Profile)
Chief Supply Chain Officer (CSCO) & Global Manufacturing Head

Toshiyuki Kurata, MBA Profile

Apr. 1995 Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited)
Apr. 2016 Director, Bio Process Research and Development Laboratories, Production Division, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Apr. 2019 Director, Production Planning department, Production Division, Kyowa Hakko Kirin Co., Ltd.
Apr. 2021 Executive Officer
Vice Head of Production Division &
Director, Production Planning Department, Kyowa Kirin Co., Ltd.
Apr. 2022 Executive Officer
Vice President, Head of Production Division, Kyowa Kirin Co., Ltd.
Apr. 2024 Executive Officer, Chief Supply Chain Officer (CSCO) & Vice President, Head of Production Division, Kyowa Kirin Co., Ltd.
Apr. 2025 Managing Executive Officer and Chief Supply Chain Officer (CSCO), Kyowa Kirin Co., Ltd. (to present)
Hiroshi Sonekawa (Profile)
Japan Sales & Marketing Head

Hiroshi Sonekawa Profile

Apr. 1985 Joined Kyowa Hakko Kogyo Company, Limited (presently Kyowa Kirin Company, Limited)
Apr. 2010 Deputy Director, Tokyo Branch, Sales & Marketing Division, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Company, Limited)
Apr. 2011 Director, Keiji-Hokuriku Branch, Sales & Marketing Division, Kyowa Hakko Kirin Co., Ltd.
Mar. 2013 Director, Nagoya Branch, Sales & Marketing Division, Kyowa Hakko Kirin Co., Ltd.
Apr. 2015 Executive Officer
Director, Area Marketing Strategy Department, Sales & Marketing Division, Kyowa Hakko Kirin Co., Ltd.
Jan. 2020 Executive Officer
Director, Internal Audit Department, Kyowa Kirin Co., Ltd.
Mar. 2021 Executive Officer
Vice President, Head of Sales & Marketing Division, Kyowa Kirin Co., Ltd.
Mar. 2022 Managing Executive Officer
Vice President, Head of Sales & Marketing Division, Kyowa Kirin Co., Ltd. (to present)
Steve Schaefer, MBA (Profile)
Region President, North America

Steve Schaefer, MBA Profile

May. 1991 Captain, United States Marine Corps
Jan. 1997 Primary Care and Neuroscience Sales Representative, Eli Lilly and Company, USA
Dec. 1998 Market Research Associate, New Antidepressant Team, Eli Lilly and Company, USA
Jan. 2001 Depression Commercialization Manager,
Neurosciences, Cymbalta, USA,
Eli Lilly and Company, USA
Oct. 2004
  • Pain Commercialization Manager
  • Brand Leader and Sr. Marketing Director
  • Senior Director, New Commercialization Model
  • Brand Leader and Senior Director, Cardiovascular Business
  • General Manager, Puerto Rico
  • Business Unit Leader, Specialty Health Organization
  • Next Generation Commercial Model Development

Eli Lilly and Company, USA
Jul. 2017
  • Senior Vice President, Business Unit Leader, General Medicines Business Unit
  • Senior Vice President, Business Unit Leader, Neuroscience Business Unit
  • Senior Vice President, Neuroscience BU Leader and Chief Operating Officer

Takeda Pharmaceuticals, USA
Apr. 2023 President, KKNA Director on Board of Directors, Kyowa Kirin USA Holdings, Inc. & Kyowa Kirin, Inc. (KKNA) (to present)
Jeremy Morgan (Profile)
Region President, Europe and the Rest of the World

Jeremy Morgan Profile

Sep. 1986 Sales and Marketing Positions (National, Regional and Global), Eli Lilly and Company
Sep. 2003 Managing Director, Turkey, Eli Lilly and Company
Mar. 2007 General Manager & Vice President, Australia & New Zealand, Eli Lilly and Company
Mar. 2010 General Manager & VP, Germany, Austria, Switzerland, Eli Lilly and Company
Apr. 2014 Vice President, Diabetes, International, Eli Lilly and Company
Apr. 2015 Executive sponsor of the European Gender Inclusion Network, Eli Lilly and Company
Jan. 2019 Chairman (non exec), PHMR, an international team of highly qualified health economists and research scientists
May. 2020 Senior Vice President Commercial, Kyowa Kirin International plc
Jun. 2021 NED and Chair RemCom, Arecor Therapeutics (to present)
Jan. 2023 President, Kyowa Kirin International plc (to present)
Toshiaki Uchikawa (Profile)
Global International Business Planning Head

Toshiaki Uchikawa Profile

Sep. 2003 Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited)
Apr. 2019 Director, Overseas Business Planning Department, Kyowa Kirin Co., Ltd. (to present)
Takefumi Matsushita, Ph.D., MBA (Profile)
Global Corporate Planning Head

Takefumi Matsushita, Ph.D., MBA Profile

Apr. 1999 Joined Kyowa Hakko Kogyo Co., Ltd. (presently Kyowa Kirin Co., Ltd.) as a staff scientist
Jun. 2002 Sent to BioWa, Inc., a US subsidiary specialized in technology licenses; Director and Head of Business Development since 2007
Dec. 2010 Manager, Clinical Development, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Apr. 2013 Sent to Kyowa Kirin Pharmaceutical Development, Inc. in the US; Director and Head of Planning since 2014
Apr. 2018 Deputy Director, Business Development & Head of Alliance Excellence ,Kyowa Hakko Kirin Co., Ltd.
Jul. 2019 Sent to Kirin Holdings Company Limited; Deputy general Manager, Corporate Strategy
Mar. 2022 Director, Medical Affairs Department, Kyowa Kirin Co., Ltd
Mar. 2023 Executive officer, Director, Medical Affairs Department, Kyowa Kirin Co., Ltd.
Apr. 2024 Executive officer
Director, Corporate Planning Department, Kyowa Kirin Co., Ltd. (to present)
Hideaki Matsumoto, MBA (Profile)
Global Product Strategy Head

Hideaki Matsumoto, MBA Profile

Apr. 1997 Joined Kirin Brewery Company, Limited（presently Kirin Holdings Company, Limited）
May. 2014 Managing Director, Kyowa Hakko Kirin Singapore Pte. Ltd.
May. 2018 Manager, Internal Audit Department, Kyowa Hakko Kirin Co., Ltd.（presently Kyowa Kirin Co., Ltd.）
Sep. 2021 Vice President, Global Crysvita Sales & Marketing Lead, Kyowa Kirin, Inc.（KKNA）
Jan. 2023 Senior Vice President, Global Crysvita Franchise Head, Kyowa Kirin, Inc.（KKNA）
Mar. 2025 Executive Officer
Director, Global Product Strategy Department, Kyowa Kirin Co., Ltd.（to present）
Wayne Bowler, Ph.D. (Profile)
Global Business Development Head

Wayne Bowler, Ph.D. Profile

1999 Fellow, Arthritis Research Council UK
2001 Research Lead Bone & Skin, Strakan Pharmaceuticals
2005 Business Development Manager, Prostrakan Pharmaceuticals
2008 Business Development Director, Prostrakan Parmaceuticals
2010 VP Business Development, Prostrakan Pharmaceuticals
2012 Senior VP Business Development, Kyowa Kirin International plc (to present)
Nathan Hawes, MBA (Profile)
Global Operational and Digital Transformation Head

Nathan Hawes, MBA Profile

Jun. 1993 Joined SmithKline Beecham (presently GlaxoSmithKline)
Apr. 1999 Planning & IT Director, SmithKline Beecham (presently GlaxoSmithKline)
Mar. 2005 Supply Chain Strategy Director, GlaxoSmithKline
Jan. 2007 Supply Chain & ERP Transformation Head, GlaxoSmithKline (Japan)
Jun. 2013 Global Supply Chain Transformation Head, GlaxoSmithKline (Singapore)
Dec. 2016 Regional Head of Supply Chain, Europe, GlaxoSmithKline
Jan. 2019 Regional Head of Supply Chain, Kyowa Kirin International plc.
Oct. 2023 Head of Global Business Transformation, Kyowa Kirin Co., Ltd.
Apr. 2025 Global Operational & Digital Transformation Head, Kyowa Kirin Co., Ltd. (to present)
Takuo Hirose (Profile)
Global Information and Communication Technology Head

Takuo Hirose Profile

Oct. 2018 Joined Kyowa Hakko Kirin Co., Ltd.(presently Kyowa Kirin Co., Ltd.)
Apr. 2019 Director, ICT Solution Department, Kyowa Hakko Kirin Co., Ltd.(presently Kyowa Kirin Co., Ltd.) (to present)
Takaaki Uochi, Ph.D. (Profile)
Global Corporate Social Responsibility (CSR) Head

Takaaki Uochi, Ph.D. Profile

Apr. 1998 Joined Kyowa Hakko Kogyo Co., Ltd. (presently Kyowa Kirin Co., Ltd.) as a staff scientist
Apr. 2010 Manager, Human Resources Department, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Apr. 2017 Manager, Corporate Strategy Planning Department, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Apr. 2021 Deputy Director and Head of Secretarial group, Human Resources Department, Kyowa Kirin Co., Ltd.
Jun. 2023 Representative Director of the Board, President, Kyowa Kirin Korea Co., Ltd.
Mar. 2025 Director, CSR Management Department, Kyowa Kirin Co., Ltd. (to present)
Kazuki Nemoto (Profile)
Global Legal Head

Kazuki Nemoto Profile

Apr. 1994 Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited)
Apr. 2014 Deputy Director, Legal Department, Kirin Holdings Company, Limited
Jan. 2022 General Manager, Legal Department, Kirin Holdings Company, Limited
Oct. 2022 Deputy Director, Legal and Intellectual Property Department, Kyowa Kirin Co., Ltd.
Apr. 2023 Director, Legal Department, Kyowa Kirin Co., Ltd. (to present)
Ian Duguid PhD, MRPharmS (Profile)
Global Regulatory Affairs Head

Ian Duguid PhD, MRPharmS Profile

Oct. 1992 Registration Scientist, Bayer Plc
May. 1995 Scientific and Regulatory Affairs Manager, Bausch & Lomb Inc
Jun. 1996 Senior Registration Manager, British Biotech Pharmaceutical Ltd
Apr. 1999 Regulatory Affairs Director, Knoll Ltd
Jul. 2002 Head of Regulatory Affairs, Strakan Pharmaceuticals Ltd
Apr. 2010 Senior VP Regulatory Affairs, Prostrakan Ltd/ Kyowa Kirin International plc
Feb. 2020 Global Regulatory Affairs Head,
Kyowa Kirin International plc (to present)
Jonathan Patroni, MBA (Profile)
Global Quality Assurance Head

Jonathan Patroni, MBA Profile

Jan. 1996 QA Process Analyst, Merck Pharmaceuticals, Merck Manufacturing Division
Nov. 1998 Production Supervisor, Merck Pharmaceuticals, Merck Manufacturing Division
Nov. 2001 QA Manager, QA Technical Services; Product Disposition; Compliance and Validation, Johnson & Johnson Pharmaceuticals
Feb. 2008 QA Director, Global Compliance & Quality Systems, Wyeth/Pfizer Pharmaceuticals
May. 2009 Senior Director, Quality Systems; Global QA External Supply, Shire/Takeda Pharmaceuticals
Jan. 2013 Vice President, Global QA External Supply, Shire/Takeda Pharmaceuticals
Oct. 2013 Vice President, QA Internal/External, Biological & Small Molecules, Shire/Takeda Pharmaceuticals
Apr. 2016 Vice President Quality, Shire/Takeda Pharmaceuticals
Feb. 2019 Global Quality Assurance Head,
Kyowa Kirin, Inc. (KKNA) (to present)
Yoshifumi Torii, Ph.D. (Profile)
Global Research Head

Yoshifumi Torii, Ph.D. Profile

Apr. 1994 Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited)
Oct. 2017 President & CEO, Fujifilm Kyowa Kirin Biologics Co., Ltd.
Oct. 2019 Deputy Director, Business Planning Department, Kyowa Kirin Co., Ltd.
Mar. 2020 Executive Officer
Vice President, Head of R&D Division,
Kyowa Kirin Co., Ltd.
Jan. 2024 Executive Officer
Vice President, Head of Research Division,
Kyowa Kirin Co., Ltd. (to present)
Ernesto Aycardi (Profile)
Global Development Head

Ernesto Aycardi Profile

Dec. 1991 Clinical Neurologist.
Military Hospital Bogota Colombia
Jul. 2006 Senior Director Worldwide Clinical Research
Merck & Co
Jul. 2012 Medical Director, Neurodegeneration, Pain and Peripheral nerve disorders
Biogen Idec
Nov. 2013 Head Late development Neurology Fertility Endocrinology
EMD Serono, Inc
Mar. 2016 Vice president TA head Migraine and Headache
Teva Pharmaceuticals
Dec. 2017 Vice president Head Clinical Operations, DM, Biometrics and Clinical Pharmacology
Teva Pharmaceuticals
Mar. 2018 Chief Medical Officer
Xenon Pharmaceuticals
Apr. 2021 Chief Development Officer,
Kyowa Kirin Inc. (KKNA) (to present)
Eslie Dennis, MD, MBChB, FCP(SA) (Profile)
Global Medical Affairs Head

Eslie Dennis, MD, MBChB, FCP(SA) Profile

Jan. 1987 Physician, Mpilo and Central Hospitals, Zimbabwe; Groote Schuur Hospital, South Africa
Jun. 1997 Medical Advisor, Merck, Sharp and Dohme South Africa
Jul. 1998 Medical Director and Medical Head South Africa, Novartis South Africa
Jul. 2000 Global Communications Manager, Novartis Switzerland
Aug. 2001 Sr Medical Dir. Gastroenterology; Exec. Director & Head: Medical Information & Comms; Exec. Director & Head: Safety Risk Management; Vice President & Medical Head Northeast, Novartis US
Oct. 2010 Exec. Director PKD Consortium and Predictive Safety Testing Consortium, Critical Path Institute
Jan. 2012 Vice President Global Scientific Affairs/Medical Affairs, Roche Tissue Diagnostics, Tucson AZ
May. 2021 Chief Medical Officer, Senior Vice President and Head North America Medical Affairs, Kyowa Kirin, Inc. (KKNA)
Mar. 2024 Global Medical Affairs Head, Kyowa Kirin, Inc. (KKNA) (to present)
Nilay Gami (Profile)
Global Pharmacovigilance Head

Nilay Gami Profile

Dec. 2001 Pharmacist & Pharmacy Manager, Ahold USA
Mar. 2007 Diabetes, Metabolic, Ophthalmology Therapeutic Area , Benefit & Risk Management, Pfizer
Nov. 2010 Senior Safety Officer (US), Worldwide Safety, Pfizer
Aug. 2013 Team Leader, Global Operations, Worldwide Safety, Pfizer
Nov. 2015 Global Head Case Management, Office of Consumer Medical Safety, Johnson & Johnson
Apr. 2020 Global Head, Pharmacovigilance Operations,
North America, Head of Pharmacovigilance,
Kyowa Kirin, Inc. (KKNA)
Sep. 2023 Global Pharmacovigilance Head, Kyowa Kirin Co., Ltd. (to present)
Ikuko Okubo, MBA (Profile)
Global Intellectual Property Head

Ikuko Okubo, MBA Profile

Apr. 1993 Joined Kyowa Hakko Kogyo Co., Ltd.(presently Kyowa Kirin Co., Ltd.)
Apr. 2012 Senior Manager, Intellectual Property Department, Kyowa Hakko Kirin Co., Ltd.(presently Kyowa Kirin Co., Ltd.)
Apr. 2015 Manager, Corporate Strategy and Planning Department, Kyowa Hakko Kirin Co., Ltd.
Apr. 2017 Deputy Director, Legal and Intellectual Property Department, Kyowa Hakko Kirin Co., Ltd.
Apr. 2022 Director, Legal and Intellectual Property Department, Kyowa Kirin Co., Ltd.
Apr. 2023 Director, Intellectual Property Department, Kyowa Kirin Co., Ltd.
Mar. 2025 Executive Officer
Director, Intellectual Property Department, Kyowa Kirin Co., Ltd. (to present)
Naohiko Kubo (Profile)
Global Finance Head

Naohiko Kubo Profile

Apr. 1996 Joined Kyowa Hakko Kogyo Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Apr. 2024 Director, Finance Department, Kyowa Kirin Co., Ltd.
Mar. 2025 Executive Officer
Director, Finance Department, Kyowa Kirin Co., Ltd. (to present)
Hiroki Nakamura (Profile)
Global Corporate Communications Head

Hiroki Nakamura Profile

Apr. 1996 Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited)
Oct. 2012 Manager, Public Relations Group, Corporate Communications Department Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Apr. 2024 Director, Corporate Communications Department, Kyowa Kirin Co., Ltd. (to present)
Masahiro Hara, MBA (Profile)
Global Procurement Head

Masahiro Hara, MBA Profile

Apr. 1996 Joined Kyowa Hakko Kogyo Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Apr. 2010 Treasurer, Kyowa Hakko Kirin America Inc.
Oct. 2020 Deputy Director, Business Development, Kyowa Hakko Kirin Co., Ltd.
Nov. 2021 Senior Manager, Corporate Planning, Kirin Holdings Co., Ltd.
Apr. 2024 Director, Procurement Department, Kyowa Kirin Co., Ltd. (to present)
Emi Arakawa, Ph.D. (Profile)
Global General Affairs Head

Emi Arakawa, Ph.D. Profile

Apr. 1992 Joined Kyowa Hakko Kogyo Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Apr. 2017 Director, Fuji Research Park, R&D Division, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Apr. 2021 Director, General Affairs Department, Kyowa Kirin Co., Ltd. (to present)
Atsushi Matsumoto, Ph.D. (Profile)
Global Supply Chain Management Head

Atsushi Matsumoto, Ph.D. Profile

Apr. 1993 Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited)
Oct. 2017 Director, CMC Development Department, Production Division, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Jan. 2020 President and CEO, Fujifilm Kyowa Kirin Biologics Co., Ltd.
Mar. 2022 Executive Officer, Kyowa Kirin Co., Ltd.
President and CEO, Fujifilm Kyowa Kirin Biologics Co., Ltd.
Mar. 2023 Executive Officer, Director, Supply Chain Management Department, Kyowa Kirin Co., Ltd. (to present)
Kenji Shibata, Ph.D. (Profile)
Global Internal Audit Head

Kenji Shibata, Ph.D. Profile

Apr. 1992 Joined Kyowa Hakko Kogyo Co, Ltd. (presently Kyowa Kirin Co, Ltd.)
Apr. 2004 Senior Research Scientist, Tokyo Res. Labs., Kyowa Hakko Kogyo Co., Ltd.
Jul. 2009 Manager, Research Planning Dept., Research Div., Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co, Ltd.)
Apr. 2012 Group Head, Discovery Res. Labs., Research Div., Kyowa Hakko Kirin Co., Ltd.
Apr. 2014 Group Head, R&D Planning Dept., R&D Div., Kyowa Hakko Kirin Co., Ltd.
Apr. 2016 Deputy Director, R&D Planning Dept., R&D Div., Kyowa Hakko Kirin Co., Ltd.
Apr. 2018 Director, R&D Planning Dept., R&D Div., Kyowa Hakko Kirin Co., Ltd.
Mar. 2021 Executive Officer
Director, Internal Audit Department, Kyowa Kirin Co., Ltd. (to present)